Geovax Labs Inc (OTCMKTS:GOVX) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as low as $0.06. Geovax Labs shares last traded at $0.06, with a volume of 64,406 shares.
The company has a market capitalization of $70,000.00, a PE ratio of -0.01 and a beta of 0.28. The firm has a 50 day simple moving average of $0.37.
Geovax Labs (OTCMKTS:GOVX) last released its earnings results on Monday, May 13th. The biotechnology company reported ($1.43) EPS for the quarter. The firm had revenue of $0.36 million during the quarter. On average, equities research analysts forecast that Geovax Labs Inc will post -3.3 earnings per share for the current year.
Geovax Labs Company Profile (OTCMKTS:GOVX)
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers.
Featured Article: Net Margin
Receive News & Ratings for Geovax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Geovax Labs and related companies with MarketBeat.com's FREE daily email newsletter.